Patient registry: Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Study summary
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Male or female patients 18 years or older
* Written informed consent
* Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Exclusion Criteria:
\- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Primary outcome measure(s)
Overall survival — 20 years Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to intervention and baseline characteristics
Trial sites (1)
Facility
City
Region
Status
Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII
Bergamo
Italy
Recruiting
More A.O. Ospedale Papa Giovanni XXIII trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.